Filing Details

Accession Number:
0001225208-17-005371
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-03-02 17:16:15
Reporting Period:
2017-02-28
Filing Date:
2017-03-02
Accepted Time:
2017-03-02 17:16:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
200406 Johnson & Johnson JNJ Pharmaceutical Preparations (2834) 221024240
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1673416 J Gary Pruden One Johnson &Amp; Johnson Plaza
New Brunswick NJ 08933
Exec Vp, Ww Chair, Med Devices No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-02-28 16,299 $122.21 43,630 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 96 Indirect By ESOP
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $122.16 to $122.26. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.